These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410 [TBL] [Abstract][Full Text] [Related]
4. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma. Bartow RA; Brogden RN Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248 [TBL] [Abstract][Full Text] [Related]
5. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. Dyer MJ; Halpin DM; Stein K BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053 [TBL] [Abstract][Full Text] [Related]
6. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Frois C; Wu EQ; Ray S; Colice GL Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019 [TBL] [Abstract][Full Text] [Related]
7. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Ni CM; Greenstone IR; Ducharme FM Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751 [TBL] [Abstract][Full Text] [Related]
8. Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids. Hancox RJ; Taylor DR BioDrugs; 2001; 15(1):11-24. PubMed ID: 11437672 [TBL] [Abstract][Full Text] [Related]
9. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Markham A; Jarvis B Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128 [TBL] [Abstract][Full Text] [Related]
10. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409 [TBL] [Abstract][Full Text] [Related]
11. The use of inhaled formoterol in the treatment of asthma. Berger WE Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777 [TBL] [Abstract][Full Text] [Related]
12. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease. Sovani MP; Whale CI; Tattersfield AE Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154 [TBL] [Abstract][Full Text] [Related]
13. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma. Lyseng-Williamson KA; Plosker GL Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627 [TBL] [Abstract][Full Text] [Related]
14. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma. Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847 [TBL] [Abstract][Full Text] [Related]
15. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses. Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003 [TBL] [Abstract][Full Text] [Related]
17. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Kalra S; Swystun VA; Bhagat R; Cockcroft DW Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376 [TBL] [Abstract][Full Text] [Related]
18. Drugs for asthma. Med Lett Drugs Ther; 2020 Dec; 62(1613):193-200. PubMed ID: 33446622 [No Abstract] [Full Text] [Related]
19. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691 [TBL] [Abstract][Full Text] [Related]
20. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma. Campbell LM Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]